News Press Releases

2nd Annual Gabelli Funds - Columbia Business School Healthcare Symposium (Virtual) - Friday, November 13, 2020

CVS, GAMI, PFE, REGN, TDOC, MRNA | November 2, 2020

NY-GABELLI-FUNDS

Join us as we discuss today’s pressing healthcare issues.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201102005244/en/

Bunny Ellerin, Director, HPM, Columbia Business School, MBA, Harvard Business School, BA, Columbia University (Photo: Business Wire)

CO-HOSTS:	Bunny Ellerin Director, HPM, Columbia Business School	Jing He Biotech Analyst, Gabelli Funds
	MBA, Harvard Business School BA, Columbia University	MBA, Columbia Business School MA, Washington University in St. Louis BS, Peking University
Time	Agenda
9:00 – 9:10 AM	Welcome Bunny Ellerin, Director, Healthcare and Pharmaceutical Management Program
9:10 – 10:00 AM	Vaccines & Therapeutics to Treat COVID-19 David Hering, Regional President, North America, Pfizer Vaccines Dr. Robert Paris, Vice President, Infectious Diseases, Moderna Dr. David Weinreich, Senior Vice President, Global Clinical Development, Regeneron (Moderator) Jing He ‘15, Biotech Analyst, Gabelli Funds
10:10 – 11:00 AM	Health Policy & Reimbursement Trends Dr. Deepa Kumaraiah, Senior Vice President, Service Lines and Chief Physician, NYP Medical Groups, NewYork-Presbyterian Melissa Schulman, Senior Vice President of Government Affairs, CVS Health Professor Michael Sparer, Chair, Health Policy and Management, Columbia University Mailman School of Public Health (Moderator) Jeff Jonas, Portfolio Manager, Gabelli Funds
11:10 – Noon	Healthcare Delivery in a Virtual World Dr. Amy Fahrenkopf, President, HSS Health and Senior Vice President, Hospital for Special Surgery Jason Gorevic, CEO, Teladoc Health Dr. Julie Silverstein, Divisional President, Oak Street Health (Moderator) Kevin Kedra, Healthcare Analyst, G.research

Click Here to Register

Gabelli Funds, LLC is a registered investment adviser with the Securities and Exchange Commission and is a wholly owned subsidiary of GAMCO Investors, Inc. (NYSE: GBL).